These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29261656)

  • 1. Nicotinic alpha 7 receptor agonists EVP-6124 and BMS-933043, attenuate scopolamine-induced deficits in visuo-spatial paired associates learning.
    Weed MR; Polino J; Signor L; Bookbinder M; Keavy D; Benitex Y; Morgan DG; King D; Macor JE; Zaczek R; Olson R; Bristow LJ
    PLoS One; 2017; 12(12):e0187609. PubMed ID: 29261656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors.
    Prickaerts J; van Goethem NP; Chesworth R; Shapiro G; Boess FG; Methfessel C; Reneerkens OA; Flood DG; Hilt D; Gawryl M; Bertrand S; Bertrand D; König G
    Neuropharmacology; 2012 Feb; 62(2):1099-110. PubMed ID: 22085888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel α7 nicotinic acetylcholine receptor agonist EVP-6124 enhances dopamine, acetylcholine, and glutamate efflux in rat cortex and nucleus accumbens.
    Huang M; Felix AR; Flood DG; Bhuvaneswaran C; Hilt D; Koenig G; Meltzer HY
    Psychopharmacology (Berl); 2014 Dec; 231(23):4541-51. PubMed ID: 24810107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological and behavioral profile of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-6-chinolincarboxamide (EVP-5141), a novel α7 nicotinic acetylcholine receptor agonist/serotonin 5-HT3 receptor antagonist.
    Boess FG; de Vry J; Erb C; Flessner T; Hendrix M; Luithle J; Methfessel C; Schnizler K; van der Staay FJ; van Kampen M; Wiese WB; König G
    Psychopharmacology (Berl); 2013 May; 227(1):1-17. PubMed ID: 23241647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoring long-term potentiation impaired by amyloid-beta oligomers: comparison of an acetylcholinesterase inhibitior and selective neuronal nicotinic receptor agonists.
    Kroker KS; Moreth J; Kussmaul L; Rast G; Rosenbrock H
    Brain Res Bull; 2013 Jul; 96():28-38. PubMed ID: 23639920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of spiroguanidine-derived α7 neuronal nicotinic receptor partial agonists.
    Hill MD; Fang H; Digavalli SV; Healy FL; Gallagher L; Post-Munson D; Chen P; Natale J; Benitex Y; Morgan D; Lodge N; Bristow L; Macor JE; Olson RE
    Bioorg Med Chem Lett; 2017 Feb; 27(3):578-581. PubMed ID: 27993517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Novel, Nicotinic Alpha7 Receptor Partial Agonist, BMS-933043, Improves Cognition and Sensory Processing in Preclinical Models of Schizophrenia.
    Bristow LJ; Easton AE; Li YW; Sivarao DV; Lidge R; Jones KM; Post-Munson D; Daly C; Lodge NJ; Gallagher L; Molski T; Pieschl R; Chen P; Hendricson A; Westphal R; Cook J; Iwuagwu C; Morgan D; Benitex Y; King D; Macor JE; Zaczek R; Olson R
    PLoS One; 2016; 11(7):e0159996. PubMed ID: 27467081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normalizing effects of EVP-6124, an α-7 nicotinic partial agonist, on event-related potentials and cognition: a proof of concept, randomized trial in patients with schizophrenia.
    Preskorn SH; Gawryl M; Dgetluck N; Palfreyman M; Bauer LO; Hilt DC
    J Psychiatr Pract; 2014 Jan; 20(1):12-24. PubMed ID: 24419307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of BMS-902483, an α7 nicotinic acetylcholine receptor partial agonist, on cognition and sensory gating in relation to receptor occupancy in rodents.
    Pieschl RL; Miller R; Jones KM; Post-Munson DJ; Chen P; Newberry K; Benitex Y; Molski T; Morgan D; McDonald IM; Macor JE; Olson RE; Asaka Y; Digavalli S; Easton A; Herrington J; Westphal RS; Lodge NJ; Zaczek R; Bristow LJ; Li YW
    Eur J Pharmacol; 2017 Jul; 807():1-11. PubMed ID: 28438647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive enhancing properties and tolerability of cholinergic agents in mice: a comparative study of nicotine, donepezil, and SIB-1553A, a subtype-selective ligand for nicotinic acetylcholine receptors.
    Bontempi B; Whelan KT; Risbrough VB; Lloyd GK; Menzaghi F
    Neuropsychopharmacology; 2003 Jul; 28(7):1235-46. PubMed ID: 12700710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Automated Patch Clamp Assay for Evaluation of α7 Nicotinic Acetylcholine Receptor Agonists in Automated QPatch-16.
    Hao Y; Tang J; Wang K
    Assay Drug Dev Technol; 2015 Apr; 13(3):174-84. PubMed ID: 25880723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological Characterization of the Novel and Selective
    Wang X; Daley C; Gakhar V; Lange HS; Vardigan JD; Pearson M; Zhou X; Warren L; Miller CO; Belden M; Harvey AJ; Grishin AA; Coles CJ; O'Connor SM; Thomson F; Duffy JL; Bell IM; Uslaner JM
    J Pharmacol Exp Ther; 2020 May; 373(2):311-324. PubMed ID: 32094294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling a task that is sensitive to dementia of the Alzheimer's type: individual differences in acquisition of a visuo-spatial paired-associate learning task in rhesus monkeys.
    Taffe MA; Weed MR; Gutierrez T; Davis SA; Gold LH
    Behav Brain Res; 2004 Mar; 149(2):123-33. PubMed ID: 15129776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A computer-automated touchscreen paired-associates learning (PAL) task for mice: impairments following administration of scopolamine or dicyclomine and improvements following donepezil.
    Bartko SJ; Vendrell I; Saksida LM; Bussey TJ
    Psychopharmacology (Berl); 2011 Mar; 214(2):537-48. PubMed ID: 21086119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia and the Use of Auditory Sensory Gating as a Translational Biomarker.
    Hashimoto K
    Curr Pharm Des; 2015; 21(26):3797-806. PubMed ID: 26044974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective activation of α7 nicotinic acetylcholine receptor by PHA-543613 improves Aβ25-35-mediated cognitive deficits in mice.
    Sadigh-Eteghad S; Talebi M; Mahmoudi J; Babri S; Shanehbandi D
    Neuroscience; 2015 Jul; 298():81-93. PubMed ID: 25881725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cholinergic neurotransmission modulation on visual spatial paired associate learning in healthy human adults.
    Harel BT; Pietrzak RH; Snyder PJ; Maruff P
    Psychopharmacology (Berl); 2013 Aug; 228(4):673-83. PubMed ID: 23568575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentration-response relationship of the α7 nicotinic acetylcholine receptor agonist FRM-17874 across multiple in vitro and in vivo assays.
    Stoiljkovic M; Leventhal L; Chen A; Chen T; Driscoll R; Flood D; Hodgdon H; Hurst R; Nagy D; Piser T; Tang C; Townsend M; Tu Z; Bertrand D; Koenig G; Hajós M
    Biochem Pharmacol; 2015 Oct; 97(4):576-589. PubMed ID: 26206187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's disease.
    Bitner RS; Bunnelle WH; Decker MW; Drescher KU; Kohlhaas KL; Markosyan S; Marsh KC; Nikkel AL; Browman K; Radek R; Anderson DJ; Buccafusco J; Gopalakrishnan M
    J Pharmacol Exp Ther; 2010 Sep; 334(3):875-86. PubMed ID: 20504913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapeutic potential of α7 nicotinic acetylcholine receptor (α7 nAChR) agonists for the treatment of the cognitive deficits associated with schizophrenia.
    Beinat C; Banister SD; Herrera M; Law V; Kassiou M
    CNS Drugs; 2015 Jul; 29(7):529-42. PubMed ID: 26242477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.